New drug delivery method targets cancer cells – not the entire body – and limits chemotherapy side effects
Chemotherapeutic drugs excel at fighting cancer, but they’re not so efficient at getting where they need to go.
They often interact with blood, bone marrow and other healthy bodily systems. This dilutes the drugs and causes unwanted side effects.
Now, researchers are developing a better delivery method by encapsulating the drugs in nanoballoons – which are tiny modified liposomes that, upon being struck by a red laser, pop open and deliver concentrated doses of medicine.
Described April 3 in the journal Nature Communications, the innovation could improve cancer treatment, reduce its side effects and boost research about the disease, which annually kills millions of people worldwide.
The paper, “Porphyrin-phospholipid (PoP) liposomes permeabilized by near-infrared light,” is available here:
“Why PoP-liposomes, or nanoballoons, open in response to an otherwise harmless red laser is still a bit of a mystery to us, but we have definitely unearthed a new and unique phenomenon,” said corresponding author Jonathan Lovell, PhD, UB assistant professor of biomedical engineering. “Its potential for improving how we treat cancer is immense.”
Additional authors include students and a research technician at UB, as well as collaborators from the University at Albany; Roswell Park Cancer Institute in Buffalo; and the University of Waterloo and McMaster University, both in Ontario, Canada.
Roughly 1,000 times thinner than human hair, nanoballoons consist of porphyrin, an organic compound, and phospholipid, a fat similar to vegetable oil. Like conventional chemotherapy, they would be delivered to patients intravenously.
But because the nanoballoons encapsulate the anti-cancer drugs, they diminish the drugs’ interaction with healthy bodily systems.
In laboratory experiments performed with mice, Lovell hits the nanoballoon with a red laser at the target site in the body. The laser triggers the nanoballoons to pop open and release the drugs. As soon as the laser is turned off, the nanoballoons close, taking in proteins and molecules that might induce cancer growth. Doctors could then be able to retrieve the nanoballoons by drawing blood or taking a biopsy.
Thus, the nanotechnology could provide a “chemical snapshot” of the tumor’s environment, which otherwise is very difficult to assess.
“Think of it this way,” Lovell said. “The nanoballoon is a submarine. The drug is the cargo. We use a laser to open the submarine door which releases the drug. We close the door by turning the laser off. We then retrieve the submarine as it circulates through the bloodstream.”
Lovell will continue fundamental studies to better understand why the treatment works so well in destroying tumors in mice, and to optimize the process. Human trials could start within five years, he said.
The Latest on: Drug delivery method
via Google News
The Latest on: Drug delivery method
- Ultrasound Enhances Drug Delivery to Treat Brain Metastaseson October 14, 2021 at 8:28 am
Proof-of-concept study shows MR-guided focused ultrasound enhances drug delivery to better treat brain metastases in HER2+ breast cancer patients.
- Central Nervous System Drug Delivery Market Size Anticipated to Grow at a CAGR of 4.1% During the Forecast Period 2021-2026on October 14, 2021 at 8:25 am
Increasing Consumer Awareness Regarding Such Drug Delivery Coupled With Rising Prevalence of Biological Therapies Are Amongst the Major Factor Projected to Impel Growth of Central Nervous System Drug ...
- $31.6B Global Drug Delivery Devices Market 2021-2027 Featuring Profiles of 25 Leading Players Including Pfizer, J&J, Roche, Novartis, and 3Mon October 14, 2021 at 6:30 am
The "Global Drug Delivery Devices Market (2021-2027) by device type, route of administration, application, end-user, vehicle outlook, ...
- Drug delivery firm Midatech Pharma expands with larger HQ moveon October 14, 2021 at 4:48 am
Drug delivery life sciences firm Midatech Pharma has expanded to larger headquarters in Cardiff. The company has moved to the 1 Caspian Point office building in Cardiff Bay, which forms part of the ...
- Implantable Drug Delivery Devices Market 2021 Share, Global Future Growth, Size, Leading Players, Future Investments by Forecast to 2030on October 12, 2021 at 11:06 pm
In a recent published report, Kenneth Research has updated the market report for Implantable Drug Delivery Devices Market for 2021 till 2030. Report ...
- Leading NEO Psych Stock Files for International Patent Covering New Delivery Methodson October 12, 2021 at 6:59 am
Biotech company Cybin Inc. (NEO: CYBN, NYSE American: CYBN, Forum) announced on Tuesday that it had filed an international patent application related to methods for the delivery of psychedelic ...
- Cybin Files an International Patent Application Covering Psychedelic Delivery Methodson October 12, 2021 at 4:00 am
Cybin Inc. ( NEO:CYBN) (NYSE AMERICAN:CYBN) (" Cybin " or the " Company "), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed an international ...
- Oral Controlled Release Drug Delivery Technology Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2027on October 12, 2021 at 4:00 am
Future Market Insights (FMI), in its report, projects the global oral controlled release drug delivery technology market to register an impressive expansion at 7.2% CAGR during the forecast period ...
- Innovative Research Methodology for drugs delivery in disaster area, using drones’ technologyon October 11, 2021 at 8:09 am
Introduction In the past, qualitative research proceeded based on genuinely moderate concerns to safeguard its points of view and practices. In recent times, qualitative scientists have started to tos ...
- Global Intranasal Drug Delivery Market to Reach $71.3 Billion by 2026on October 11, 2021 at 5:28 am
Abstract: Global Intranasal Drug Delivery Market to Reach $71. 3 Billion by 2026 . As a direct result of technological advancements and increasing awareness among physicians and patients, a number of ...
via Bing News